There is a growing focus on equitable access to clinical trials, particularly in the context of ovarian cancer care. The concept of a "next frontier" is being explored in various aspects of healthcare, including clinical research, pharmaceutical development, and genomic medicine. It appears that different fields, including cancer care and pharmaceuticals, are seeking to expand access and improve health equity, although the specific approaches and areas of focus are not clearly defined.